HCPLive Network

Gastric Bypass Drastically Lowers Cholesterol

TUESDAY, June 11 (HealthDay News) -- Compared to gastric banding, bariatric bypass surgery achieves greater cholesterol lowering, according to a study published in the June issue of Diabetes Care.

Alberto Benetti, MD, from Universita degli Studi di Milano, and colleagues assessed glucose metabolism (blood glucose and serum insulin levels and homeostasis model assessment of insulin resistance [HOMA-IR] index) and cholesterol metabolism (absorption: serum campesterol and sitosterol levels; synthesis: serum lathosterol levels; catabolism: rate of appearance and serum concentrations of serum 7-α- and serum 27-OH-cholesterol after infusions of deuterated 7-α- and 27-OH-cholesterol in sequence) in grade 3 obesity subjects undergoing bariatric bypass surgery and gastric banding. Measurements were taken before and six months after surgery.

The researchers found that baseline values were similar in all subjects. In both groups, weight loss and blood glucose, insulin levels, HOMA-IR, and triglycerides decreased similarly. Serum cholesterol, low-density lipoprotein cholesterol, non-high-density lipoprotein cholesterol, serumsitosterol, and campesterol levels decreased and lathosterol levels increased only in bypass subjects. Serum 27-OH-cholesterol decreased in both groups, but only in the bypass group was there a significant increase in 7-α-OH-cholesterol.

"Malabsorptive surgery specifically affects cholesterol levels, independent of weight loss and independent of glucose metabolism and insulin resistance," the authors write.

Abstract
Full Text (subscription or payment may be required)

Copyright © 2013 HealthDay. All rights reserved.

Further Reading
Two-thirds of dietary supplements recalled by the US Food and Drug Administration because they contained banned ingredients remained on store shelves at least six months after they were recalled, according to a research letter published in the Oct. 22/29 issue of the Journal of the American Medical Association.
A team-based approach using evidence-based principles can be incorporated into practice workflow to improve hypertension control, according to a practice story published by the American Medical Association.
Carol Burke, MD, FACG, FASGE, talks about her phase-3 placebo-controlled trial of Celecoxib in pediatric subjects with familial adenomatous polyposis (FAP) at the 2014 ACG Annual Meeting in Philadelphia, PA.
Carol Burke, MD, FACG, FASGE, discusses pediatric familial adenomatous polyposis (FAP) and colorectal cancer at the 2014 ACG Annual Scientific Meeting in Philadelphia, PA.
Black women undergoing in vitro fertilization are only about half as likely as white women to become pregnant, and the racial disparity persists even when donor eggs are used. These findings are being presented at the annual meeting of the American Society for Reproductive Medicine, held from Oct. 18 to 22 in Honolulu.
Hospital conversion to for-profit status is associated with improvements in financial margins, but has no effect on process quality metrics or mortality rates, according to a study published in the Oct. 22/29 issue of the Journal of the American Medical Association
Drinking sugar-sweetened sodas may affect cellular aging by shortening telomere length, according to research published online Oct. 16 in the American Journal of Public Health.
More Reading